Literature DB >> 18336332

Synthesis and endothelin receptor binding affinity of a novel class of 2-substituted-4-aryl-3-quinolinecarboxylic acid derivatives.

Valeria Pittalà1, Maria Modica, Loredana Salerno, Maria Angela Siracusa, Francesco Guerrera, Ilario Mereghetti, Alfredo Cagnotto, Tiziana Mennini, Giuseppe Romeo.   

Abstract

The 21-amino acid peptide endothelin-1 (ET-1) is the predominant isoform of the endothelin peptide family, which includes ET-2, and ET-3. These peptides display a variety of physiological activities including vasoconstriction and the stimulation of cell proliferation in tissues both within and outside of the cardiovascular system. They exert their actions via activation of two distinct receptor subtypes, ET(A) and ET(B), belonging to the G protein-coupled receptor (GPCR) superfamily. Ligands of these receptors have received numerous citations in the recent pharmaceutical literature. In particular receptor antagonists, both ET(A)- and ET(B)-selective, as well as non-selective, have been described due to their wide therapeutic potential. As a part of our program toward the development of selective ET(A) ligands we have designed and we now report new molecules based on 2-substituted-4-aryl-3-quinolinecarboxylic acid moiety. Binding profile for some compounds (40, 44, 46, and 47) of this class showed a reasonable affinity and selectivity for ET(A) receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336332     DOI: 10.2174/157340608783789095

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  2 in total

1.  Ethyl 2,6-dichloro-4-phenyl-quinoline-3-carboxyl-ate.

Authors:  S Mohana Roopan; F Nawaz Khan; M Vijetha; Venkatesha R Hathwar; Seik Weng Ng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-11-04

2.  Synthesis and Molecular Modelling Studies of New 1,3-Diaryl-5-Oxo-Proline Derivatives as Endothelin Receptor Ligands.

Authors:  Sebastiano Intagliata; Mohamed A Helal; Luisa Materia; Valeria Pittalà; Loredana Salerno; Agostino Marrazzo; Alfredo Cagnotto; Mario Salmona; Maria N Modica; Giuseppe Romeo
Journal:  Molecules       Date:  2020-04-17       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.